Developing procedures for the large-scale purification of human serum butyrylcholinesterase.

[1]  O. Lockridge,et al.  LARGE SCALE PURIFICATION OF BUTYRYLCHOLINESTERASE FROM HUMAN PLASMA SUITABLE FOR INJECTION INTO MONKEYS; A POTENTIAL NEW THERAPEUTIC FOR PROTECTION AGAINST COCAINE AND NERVE AGENT TOXICITY. , 2005, The journal of medical, chemical, biological, and radiological defense.

[2]  E. Duysen,et al.  Wild-Type and A328W Mutant Human Butyrylcholinesterase Tetramers Expressed in Chinese Hamster Ovary Cells Have a 16-Hour Half-Life in the Circulation and Protect Mice from Cocaine Toxicity , 2002, Journal of Pharmacology and Experimental Therapeutics.

[3]  S. Brimijoin,et al.  Cocaine metabolism accelerated by a re-engineered human butyrylcholinesterase. , 2002, The Journal of pharmacology and experimental therapeutics.

[4]  Y. Ashani.  Prospective of human butyrylcholinesterase as a detoxifying antidote and potential regulator of controlled‐release drugs , 2000 .

[5]  N. Greig,et al.  Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase. , 1998, Experimental and clinical psychopharmacology.

[6]  R. Brady,et al.  Cocaine detoxification by human plasma butyrylcholinesterase. , 1997, Toxicology and applied pharmacology.

[7]  Y. Ashani,et al.  The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. , 1997, Toxicology and applied pharmacology.

[8]  Y. Ashani,et al.  Large-scale purification and long-term stability of human butyrylcholinesterase: a potential bioscavenger drug. , 1997, Journal of biochemical and biophysical methods.

[9]  R. Bradley,et al.  Cocaine and butyrylcholinesterase (BChE): determination of enzymatic parameters. , 1996, Life sciences.

[10]  Y. Ashani,et al.  Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats , 1993, Pharmacology Biochemistry and Behavior.

[11]  Y. Ashani,et al.  Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization. , 1993, Biochemical pharmacology.

[12]  D. W. Blick,et al.  Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity. , 1992, Toxicology and applied pharmacology.

[13]  C. A. Castro,et al.  Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. , 1991, The Journal of pharmacology and experimental therapeutics.

[14]  O. Lockridge.  Structure of human serum cholinesterase , 1988, BioEssays : news and reviews in molecular, cellular and developmental biology.

[15]  L. Skovgaard,et al.  Half–life of plasma cholinesterase , 1988, Acta anaesthesiologica Scandinavica.

[16]  O. Lockridge,et al.  Brain cDNA clone for human cholinesterase. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[17]  O. Lockridge,et al.  Complete amino acid sequence of human serum cholinesterase. , 1987, The Journal of biological chemistry.

[18]  B. P. Doctor,et al.  A simplified procedure for the purification of large quantities of fetal bovine serum acetylcholinesterase. , 1986, Life sciences.

[19]  A. Main,et al.  Use of procainamide gels in the purification of human and horse serum cholinesterases. , 1983, The Biochemical journal.

[20]  O. Lockridge,et al.  Loss of the interchain disulfide peptide and dissociation of the tetramer following limited proteolysis of native human serum cholinesterase. , 1982, The Journal of biological chemistry.

[21]  O. Lockridge,et al.  Comparison of atypical and usual human serum cholinesterase. Purification, number of active sites, substrate affinity, and turnover number. , 1978, The Journal of biological chemistry.

[22]  J. Stovner,et al.  Suxamethonium Apnoea Terminated with Commercial Serumcholinesterase , 1976, Acta anaesthesiologica Scandinavica.

[23]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[24]  T. Jenkins,et al.  Cholinesterase in Plasma: First Reported Absence in the Bantu; Half-life Determination , 1967, Science.

[25]  M. Karnovsky,et al.  A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES , 1964, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[26]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[27]  D. Surgenor,et al.  Preparation and Properties of Serum and Plasma Proteins. Plasma Cholinesterase1 , 1954 .

[28]  Y. Ashani,et al.  Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases. , 1998, Molecular pharmacology.

[29]  R. Hoffman,et al.  Administration of purified human plasma cholinesterase protects against cocaine toxicity in mice. , 1996, Journal of toxicology. Clinical toxicology.

[30]  Y. Ashani,et al.  Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. , 1991, Biochemical pharmacology.

[31]  O. Lockridge.  Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. , 1990, Pharmacology & therapeutics.

[32]  Ennis Layne,et al.  SPECTROPHOTOMETRIC AND TURBIDIMETRIC METHODS FOR MEASURING PROTEINS , 1957 .